
|Articles|March 6, 2019
Advarra Acquires Quorum Review IRB and Kinetiq
Advertisement
Advarra, provider of institutional review board (IRB), institutional biosafety committee (IBC), and research quality and compliance consulting services in North America, announced the acquisition of Quorum, one of the central IRBs in the U.S. and Canada. The transaction also includes Quorum’s research and technology consulting division, Kinetiq.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
2
ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps
3
The CRA of the Future: From Monitoring Activity to Strategic Site Partnership
4
Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad
5




